Cytolytic Vaginosis: Diagnostic Challenges and Therapeutic Approaches

Autores

  • Maria Clara Silva Bovi Universidade de Uberaba
  • Nathan Castro Silva Universidade de Uberaba
  • Lourenia Caroline Fernandes Veiga Universidade de Uberaba
  • Anna Carolina Souto Perez Universidade de Uberaba
  • Renata Cicci Cunha Castro Universidade de Uberaba
  • Flavia Ana Pacheco Universidade de Uberaba
  • Ruchele Dias Nogueira Universidade de Uberaba

DOI:

https://doi.org/10.36557/2674-8169.2025v7n8p1493-1508

Palavras-chave:

Cytolytic Vaginosis, Vaginal Microbiota, Differential Diagnosis

Resumo

Objective: This study aims to provide a comprehensive review of cytolytic vaginosis (CV), a condition often overlooked in clinical practice, to improve understanding of its pathophysiology, diagnostic challenges, and effective management strategies.

Downloads

Não há dados estatísticos.

Referências

Brolazo ET, et al. Vaginose bacteriana: estudo clínico e laboratorial em mulheres atendidas em um centro de referência. Braz. J. Periodontol. 2009;19(4):11-15.

Carvalho F. Vaginose Citolítica: Uma Revisão de Literatura. 2021.

Cerikcioglu N, Beksac MS. Cytolytic vaginosis: misdiagnosed as candidal vaginitis. Infect Dis Obstet Gynecol. 2004;12(1):13-6. doi:10.1080/10647440410001672139.

Cibley LJ, Cibley LJ. Cytolytic vaginosis. Am J Obstet Gynecol. 1991;165(4 Pt 2):1245-9. doi:10.1016/s0002-9378(12)90736-x.

Coutinho CTA, et al. Vaginose Citolítica: uma revisão de literatura. Research, Society and Development. 2022;11(13):e504111335470. doi:10.33448/rsd-v11i13.35470.

Demirezen S. Cytolytic vaginosis: examination of 2947 vaginal smears. Cent Eur J Public Health. 2003;11(1):23-4.

Fredericks DN, et al. The Vaginal Microbial Community of Women with and without Bacterial Vaginosis. The Journal of Infectious Diseases. 2002;185(4):556–558.

Gaspar C, et al. Development and Characterization of Sodium Bicarbonate-Based Gel for Cytolytic Vaginosis. Pharmaceutics. 2024;16(11):1436. doi:10.3390/pharmaceutics16111436.

Giraldo PC, et al. Vaginose citolítica: resultados e discussão. Rev. Bras. Ginecol. Obstet. 2005;27(5):254-258.

Hacısalihoğlu UP, Acet F. A Clinicopathological Diagnostic and Therapeutic Approach to Cytolytic Vaginosis: An Extremely Rare Entity that may Mimic Vulvovaginal Candidiasis. J Cytol. 2021;38(2):88-93. doi:10.4103/JOC.JOC_169_20.

Hills RL. Cytolytic vaginosis and lactobacillosis. Consider these conditions with all vaginosis symptoms. Adv Nurse Pract. 2007;15(2):45-8.

Hu Z, et al. Identification of cytolytic vaginosis versus vulvovaginal candidiasis. J Low Genit Tract Dis. 2015;19(2):152-5. doi:10.1097/LGT.0000000000000076.

Hutti MH, Hoffman C. Cytolytic vaginosis: an overlooked cause of cyclic vaginal itching and burning. J Am Acad Nurse Pract. 2000;12(2):55-7. doi:10.1111/j.1745-7599.2000.tb00284.x.

Komec S, Aydin MD. A Little-Known Vaginitis-Like Picture: Cytolytic Vaginosis. Clin Lab. 2025;71(1). doi:10.7754/Clin.Lab.2024.240709.

Kraut R, et al. Scoping review of cytolytic vaginosis literature. PLoS One. 2023;18(1):e0280954. doi:10.1371/journal.pone.0280954.

Lev-Sagie A, et al. The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions. J Low Genit Tract Dis. 2022;26(1):79-84. doi:10.1097/LGT.0000000000000644.

Lin J, et al. Sulfated glycosaminoglycans are host epithelial cell targets of the Candida albicans toxin candidalysin. Nat Microbiol. 2024;9(10):2553-2569. doi:10.1038/s41564-024-01794-8.

Menz N, et al. Efeitos da microbiota vaginal na saúde da mulher. Revista Científica UNINASSAU. 2020;1(1):49-59.

Neves LB, et al. Vaginose Citolítica: Um Diagnóstico Desafiador para o Ginecologista. Rev. Bras. Ginecol. Obstet. 2019;41(12):759-764.

Paavonen J. Vulvodynia--a complex syndrome of vulvar pain. Acta Obstet Gynecol Scand. 1995;74(4):243-7. doi:10.3109/00016349509024442.

Pereira RM, Vale JS. Vaginose Citolítica: Um Diagnóstico Desafiador para o Ginecologista. Brazilian Journal of Health Review. 2024;7(2):e12741. doi:10.34119/bjhrv7n2-049.

Qi W, et al. Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis. Front Cell Infect Microbiol. 2021;11:759795. doi:10.3389/fcimb.2021.759795.

Ramírez-Ledesma MG, et al. Extracellular Traps in Patients Diagnosed With Bacterial Vaginosis, Trichomoniasis, Candidiasis, Noninfectious Vaginitis and Cytolytic Vaginosis. Int J Microbiol. 2024;2024:7619416. doi:10.1155/2024/7619416.

Russo MG. Vaginose Citolítica: Uma Revisão de Literatura. 2023.

Sanches JM, et al. Laboratorial Aspects of Cytolytic Vaginosis and Vulvovaginal Candidiasis as a Key for Accurate Diagnosis: A Pilot Study. Rev Bras Ginecol Obstet. 2020;42(10):634-641. doi:10.1055/s-0040-1715139.

Sanches JM, et al. Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study. PLoS One. 2018;13(8):e0202401. doi:10.1371/journal.pone.0202401.

Santana JF, et al. Vaginose Citolítica: Revisão de Literatura. Revista Saúde e Pesquisa. 2025;18(1):1–15.

Secor RM. Cytolytic vaginosis: a common cause of cyclic vulvovaginitis. Nurse Pract Forum. 1992;3(3):145-8.

Silva VC, et al. Vaginose Citolítica: Revisão de Literatura. Revista Científica UNINASSAU. 2023;5(1):113–125.

Soares SR, et al. Vaginose Citolítica: Uma Revisão de Literatura. Brazilian Journal of Gynecology and Obstetrics. 2017;39(6):1–6.

Souza LAS. Diagnóstico diferencial da vaginose citolítica. Revista Brasileira de Ginecologia e Obstetrícia. 2019;31(6):306-310.

Suresh A, et al. Cytolytic vaginosis: A review. Indian J Sex Transm Dis AIDS. 2009;30(1):48-50. doi:10.4103/0253-7184.55490.

Swidsinski A, et al. Antimicrobial Susceptibility of Microbiota in Bacterial Vaginosis Using Fluorescence In Situ Hybridization. Pathogens. 2022;11(4):456. doi:10.3390/pathogens11040456.

Vieira-Baptista P, et al. Vaginal Leptothrix: An Innocent Bystander? Microorganisms. 2022;10(8):1645. doi:10.3390/microorganisms10081645.

Xu H, et al. Characterization of the vaginal microbiome during cytolytic vaginosis using high-throughput sequencing. J Clin Lab Anal. 2019;33(1):e22653. doi:10.1002/jcla.22653.

Yang S, et al. Variation of the Vaginal Lactobacillus Microbiome in Cytolytic Vaginosis. J Low Genit Tract Dis. 2020;24(4):417-420. doi:10.1097/LGT.0000000000000565.

Yang S, et al. Clinical Significance and Characteristic Clinical Differences of Cytolytic Vaginosis in Recurrent Vulvovaginitis. Gynecol Obstet Invest. 2017;82(2):137-143. doi:10.1159/000446945.

Zilnyte M, et al. The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59. Toxins (Basel). 2015;7(1):110-28. doi:10.3390/toxins7010110.

Zwittink RD, et al. Reduced heterogeneity of the vaginal microbiota following treatment for bacterial vaginosis. Frontiers in Cellular and Infection Microbiology. 2021;11:726667. doi:10.3389/fcimb.2021.726667.

Downloads

Publicado

2025-08-31

Como Citar

Bovi, M. C. S., Castro Silva, N., Veiga, L. C. F., Perez, A. C. S., Castro, R. C. C., Pacheco, F. A., & Nogueira, R. D. (2025). Cytolytic Vaginosis: Diagnostic Challenges and Therapeutic Approaches. Brazilian Journal of Implantology and Health Sciences, 7(8), 1493–1508. https://doi.org/10.36557/2674-8169.2025v7n8p1493-1508

Edição

v. 7 n. 8 (2025): BJIHS QUALIS B3 - FATOR DE IMPACTO SJIF 5.807 - ÍNDICE H 19

Seção

Revisão de Literatura

Licença

Copyright (c) 2025 Maria Clara Silva Bovi, Nathan Castro Silva, Lourenia Caroline Fernandes Veiga, Anna Carolina Souto Perez, Renata Cicci Cunha Castro, Flavia Ana Pacheco, Ruchele Dias Nogueira

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

Os autores são detentores dos direitos autorais mediante uma licença CCBY 4.0.